Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function microbiologystudy

By /


Antimicrobial Agents and Chemotherapy, Ahead of Print.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top